On Oct. 30th, the Washington Supreme Court (6-3) issued a significant decision that will shape how product liability cases are…
Read More →
The Trump administration is advancing a multilateral strategy to reinforce US leadership in AI through domestic initiatives and international diplomacy.…
Read More →
On 28 October 2025, China passed amendments to the Cybersecurity Law, marking the first update since its enactment in 2016.…
Read More →
Employers should pay close attention to two recent developments in California employment law. California Gov. Gavin Newsom recently signed Assembly…
Read More →
Last time in our blog series “Inside the Marketer’s Guide to AI”, we explored practical tips for using AI tools…
Read More →
This periodic bulletin is designed to help companies identify important legal developments governing the use and acceptance of blockchain technology,…
Read More →
When you start a medication like Dupixent (dupilumab), you expect relief from eczema or asthma, not the devastation of a…
Read More →
The pharmaceutical retailer AvKARE has published a voluntary recall notice for five different types of eye drops previously available through…
Read More →
When does the statute of repose clock start ticking on a product liability claim involving long-term repeat use of many…
Read More →
The first known lawsuit has now been filed against the makers of Dupixent (dupilumab), alleging that the popular eczema and…
Read More →